Levetiracetam (LEV) is an established second generation anti-epileptic drug and LEV associated severe cutaneous reactions are rare. Here we report the case of psoriasiform drug eruption in a patient with newly diagnosed epilepsy who had been treated with levetiracetam. To our knowledge this is the first report of a patient with a psoriasiform eruption that appeared after the administration of LEV.
作者:Onur Serdar, Gencler;Bilgen, Gencler;Cemile Tugba, Altunel;Nur, Arslan
来源:Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 2015 年 23卷 6期